HPTLC Method for Simultaneous Determination of Lopinavir and Ritonavir in Capsule Dosage Form

A rapid and simple high performance thin layer chromatography (HPTLC) method with densitometry at λ=263 nm was developed and validated for simultaneous determination of lopinavir and ritonavir from pharmaceutical preparation. Separation was performed on aluminum-backed silica gel 60F254 HPTLC plates...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Sulebhavikar, U. D. Pawar, K. V. Mangoankar, N. D. Prabhu-Navelkar
Format: Article
Language:English
Published: Wiley 2008-01-01
Series:E-Journal of Chemistry
Online Access:http://dx.doi.org/10.1155/2008/539849
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551732152893440
author A. V. Sulebhavikar
U. D. Pawar
K. V. Mangoankar
N. D. Prabhu-Navelkar
author_facet A. V. Sulebhavikar
U. D. Pawar
K. V. Mangoankar
N. D. Prabhu-Navelkar
author_sort A. V. Sulebhavikar
collection DOAJ
description A rapid and simple high performance thin layer chromatography (HPTLC) method with densitometry at λ=263 nm was developed and validated for simultaneous determination of lopinavir and ritonavir from pharmaceutical preparation. Separation was performed on aluminum-backed silica gel 60F254 HPTLC plates as stationary phase and using a mobile phase comprising of toluene, ethyl acetate, methanol and glacial acetic acid, in the volume ratio of 7.0:2.0:0.5:0.5 (v/v) respectively. After development, plates were observed under UV light. The detector response was linear in the range of 6.67 to 20.00 µg/spot and 1.67 to 5.00 µg/spot for lopinavir and ritonavir respectively. The validated lowest limit of detection was 21.00 ng/spot and 5.10 ng/spot whereas lowest limit of quantification was 7.00 ng/spot and 21.00 ng/spot for lopinavir and ritonavir respectively. The percentage assay of lopinavir and ritonavir was found between 98.23 to 102.28% and 98.03 to 103.50% respectively. The described method has the advantage of being rapid and easy. Hence it can be applied for routine quality control analysis of lopinavir and ritonavir from pharmaceutical preparation and stability studies.
format Article
id doaj-art-49b8c9ea747a4279a2307caf6f41d33f
institution Kabale University
issn 0973-4945
2090-9810
language English
publishDate 2008-01-01
publisher Wiley
record_format Article
series E-Journal of Chemistry
spelling doaj-art-49b8c9ea747a4279a2307caf6f41d33f2025-02-03T06:00:44ZengWileyE-Journal of Chemistry0973-49452090-98102008-01-015470671210.1155/2008/539849HPTLC Method for Simultaneous Determination of Lopinavir and Ritonavir in Capsule Dosage FormA. V. Sulebhavikar0U. D. Pawar1K. V. Mangoankar2N. D. Prabhu-Navelkar3Department of Chemistry, K. J. Somaiya Senior College of Science and Commerce, Vidyanagar, Vidyavihar, Mumbai-400077, IndiaDepartment of Chemistry, K. J. Somaiya Senior College of Science and Commerce, Vidyanagar, Vidyavihar, Mumbai-400077, IndiaDepartment of Chemistry, K. J. Somaiya Senior College of Science and Commerce, Vidyanagar, Vidyavihar, Mumbai-400077, IndiaDepartment of Chemistry, K. J. Somaiya Senior College of Science and Commerce, Vidyanagar, Vidyavihar, Mumbai-400077, IndiaA rapid and simple high performance thin layer chromatography (HPTLC) method with densitometry at λ=263 nm was developed and validated for simultaneous determination of lopinavir and ritonavir from pharmaceutical preparation. Separation was performed on aluminum-backed silica gel 60F254 HPTLC plates as stationary phase and using a mobile phase comprising of toluene, ethyl acetate, methanol and glacial acetic acid, in the volume ratio of 7.0:2.0:0.5:0.5 (v/v) respectively. After development, plates were observed under UV light. The detector response was linear in the range of 6.67 to 20.00 µg/spot and 1.67 to 5.00 µg/spot for lopinavir and ritonavir respectively. The validated lowest limit of detection was 21.00 ng/spot and 5.10 ng/spot whereas lowest limit of quantification was 7.00 ng/spot and 21.00 ng/spot for lopinavir and ritonavir respectively. The percentage assay of lopinavir and ritonavir was found between 98.23 to 102.28% and 98.03 to 103.50% respectively. The described method has the advantage of being rapid and easy. Hence it can be applied for routine quality control analysis of lopinavir and ritonavir from pharmaceutical preparation and stability studies.http://dx.doi.org/10.1155/2008/539849
spellingShingle A. V. Sulebhavikar
U. D. Pawar
K. V. Mangoankar
N. D. Prabhu-Navelkar
HPTLC Method for Simultaneous Determination of Lopinavir and Ritonavir in Capsule Dosage Form
E-Journal of Chemistry
title HPTLC Method for Simultaneous Determination of Lopinavir and Ritonavir in Capsule Dosage Form
title_full HPTLC Method for Simultaneous Determination of Lopinavir and Ritonavir in Capsule Dosage Form
title_fullStr HPTLC Method for Simultaneous Determination of Lopinavir and Ritonavir in Capsule Dosage Form
title_full_unstemmed HPTLC Method for Simultaneous Determination of Lopinavir and Ritonavir in Capsule Dosage Form
title_short HPTLC Method for Simultaneous Determination of Lopinavir and Ritonavir in Capsule Dosage Form
title_sort hptlc method for simultaneous determination of lopinavir and ritonavir in capsule dosage form
url http://dx.doi.org/10.1155/2008/539849
work_keys_str_mv AT avsulebhavikar hptlcmethodforsimultaneousdeterminationoflopinavirandritonavirincapsuledosageform
AT udpawar hptlcmethodforsimultaneousdeterminationoflopinavirandritonavirincapsuledosageform
AT kvmangoankar hptlcmethodforsimultaneousdeterminationoflopinavirandritonavirincapsuledosageform
AT ndprabhunavelkar hptlcmethodforsimultaneousdeterminationoflopinavirandritonavirincapsuledosageform